Skip to main content

Eisai shares fall following report of patient death in Alzheimer’s trial

Eisai Co.'s shares fell Tuesday following a report that a woman died after receiving the company's experimental Alzheimer's drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.